Methylergonovine maleate 0.2mg/mL; amp. IM: 0.2mg after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium; may be repeated as required at intervals of 2–4 ...

The tablets are used for the prevention and management of postpartum hemorrhage (PPH), a condition characterized by excessive bleeding during labor. Lupin has bolstered its portfolio by introducing ...

BALTIMORE — Lupin on Thursday announced that it would be re-introducing its Methergine (methylergonovine maleate) tablets. The drug is indicated to manage uterine atony, hemorrhage and subinvolution ...

Lupin and its US subsidiary have re-introduced Methergine (methylergonovine maleate) oral tablets 0.2mg for the prevention and management of postpartum hemorrhage (PPH). Methergine is the only ...

Lupin’s generic Methergine tablets will be available in 0.2-mg dosage strength. The product’s market size was $71.5 million for the 12 months ended April 2018, according to IQVIA data.

Drug firm Lupin has strengthened its brand portfolio in the US market with the introduction of its Methergine oral tablets used for the prevention and management of excess blood loss after delivery, ...

Granules India Ltd today said its US subsidiary has launched the generic version of Methergine (Methylergonovine Maleate) tablets, in partnership with West-Ward Pharmaceuticals Corp, a wholly-owned ...

(RTTNews) - Hikma Pharmaceuticals PLC (HIK.L) announced that its wholly-owned US subsidiary, West-Ward Pharmaceuticals Corp., has launched Methylergonovine Maleate Tablets, USP, 0.2mg, the generic ...

Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., has launched the generic version of methylergonovine maleate tablets, USP, 0.2mg the generic equivalent to ...